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Objective: The aim of this study was to investigate the situations and factors that cause nurses not to
follow standard operating procedures (SOPs) during the clinical trial process.
Methods: Five cases involving patients enrolled in a clinical trial were divided into two groups, pre-SOP
training and post-SOP training, to compare and observe the process problems and whether nurses fol-
lowed SOPs in clinical trials. The causes of problems were analyzed and corrective measures were
proposed.
Results: Our results indicate signiﬁcant improvement in compliance with SOPs after training. There
were three occurrences of irregular behavior after training compared with 21 occurrences of irregular
behavior before training.
Conclusions: The quality of clinical trials can be improved if nurses strictly follow SOPs.
© 2016 Shanxi Medical Periodical Press. Publishing services by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Standard operating procedures (SOPs) are developed to estab-
lish written standards and detailed protocols in each work envi-
ronment and operation to ensure accurate completion of clinical
trials. This study was a randomized, controlled clinical trial; the test
drug and control drug had the same dosage, appearance, color, and
taste. Researchers and participants did not know if the drug used by
the subject was the test drug or the control drug.1 This double-blind
approach avoids assessment bias (the tendency to favor new
therapies) and possible psychological effects in subjects. If subjects
know that they are using the test drug or the control, their atti-
tudes, their cooperation, and their answers to treatment questions
can be affected. Double-blind trials ensure assessment efﬁcacy,
adverse reactions are stated more objectively, and the test is more
scientiﬁcally valid. The ﬁrst topic in Good Clinical Practice (GCP)
training involves quality assurance, which stresses the need to
adopt SOPs to ensure the implementation of quality control and
quality assurance systems in clinical trials.2 Therefore, it isal Periodical Press.
blishing services by Elsevier B.V. Thimportant to strictly enforce SOPs in clinical trials to ensure the
quality of drug clinical trials.
2. Methods
2.1. Clinical data
From May 2013 to October 2014, three clinical trial programs
with 55 cases were evaluated. The inclusion criteria are as follows.
The clinical trial cases were randomized control trials that included
infusion and oral intake. The 55 clinical trial cases were divided into
pre-SOP and post-SOP training groups, containing 27 and 28 cases,
respectively. Pre-SOP and post-SOP training activities were
compared for 9 research nurses. There was no statistical signiﬁ-
cance in the general information of the two groups (P > 0.05),
which were comparable.
2.2. Methods
In the pre-SOP training group, the research nurses had standard
GCP training but not systematic SOP training. In the post-SOP
training group, the research nurses had standard GCP training
and systematic SOP training. The following aspects were carefully
observed: implementation of the standards of medicineis is an open access article under the CC BY-NC-ND license (http://creativecommons.
Table 2
Factors affecting the double-blind trial status.
Factors Number of nurses
Attitude is not rigorous 3
Not familiar with SOPs 2
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about clinical trialerelevant information, ﬁle storage, drug recov-
ery, and comparison of activities before and after training. Data
processing was done using IBM SPSS version 13.3 statistical soft-
ware. P < 0.05 was considered statistically signiﬁcant.SOPs imperfect 8
Not familiar with the program 33. Results
The quality after training was signiﬁcantly higher than the
quality before training (Tables 1 and 2).4. Strategies
4.1. All health-care workers participating in this clinical trial must
have a rigorous scientiﬁc attitude
Workers must realize that they cannot disclose information
concerning random number generation, test drug coding, subject
number, test group, experimental results and evaluation, or data
management.4.2. Standardization of job duties is a basic requirement of clinical
trials
Before the test starts, research nurses must attend a research
project discussion to become familiar with the clinical trial pro-
gram.3 Adequate preparation before the trial is required for suc-
cessful trial completion.4.3. There will be someone speciﬁcally responsible for the drugs,
which must be kept in a locked location
There will be designated store counters for clinical trial drugs
and drugs will be regularly inventoried. The time of drug removal
and administration must be recorded and signed. Empty drug
bottles and any remaining drugs shall not be discarded.44.4. Documents
After the establishment of the SOP ﬁle, responsibilities of
different staff are clariﬁed and standard operations are collected to
ensure the quality of data; even if no error occurs, there will be
documents to check.5 The operating procedures must be further
improved during clinical implementation process to guarantee that
the SOPs are always up to date. If it is a double-blind trial, during
the entire trial process, nurses will be divided into single- and
double-blinded groups for their duties. Nurses in the single-blind
group should have a separate working place; must keep their in-
formation conﬁdential; cannot randomly discuss speciﬁc circum-
stances of the trial drug with doctors, nurses, or other participants;
and the ﬁle must be separately saved. Nurses in the double-blindTable 1
Assessment of problems in operating procedures conducted by research nurse.
Violation of
operating
Before training
(occurrences)
After training
(occurrences)
Drug recovery 8 2
Talking about clinical
trial-relevant information
2 0
File storage 6 1
Unlocked location 5 0
Total 21 3
Note: Comparison of the two groups (P < 0.05).group must remain cautious in this process and be ready to
accept inspection by supervisory staff.6
4.5. The duties and practices of research nurses in a trial test
4.5.1. Double-blind nurse duties
A rigorous testing process must be based on a professional work
style, scientiﬁc management methods, and a scientiﬁc and realistic
attitude toward subjects under nurse management. (1) Before
establishing the group, nurses must be proﬁcient in trial-relevant
knowledge, implementing participant recruitment, assisting par-
ticipants in fully understanding the trial and agreeing with it, and
must use language that allows participants and families to fully and
accurately understand the details of the clinical trial. Through good
communication, participants will decide whether to sign the clin-
ical trial agreement.7 When participants completely understand
and volunteer to participate in a trial, attention must be paid to
psychologically building mutual trust between the nurse and the
participant to improve trial compliance. (2) Research nurses must
administer medicine strictly according to the SOP trial imple-
mentation program. Before following the doctor's prescription,
nurses must repeatedly read treatment programs to further un-
derstand relevant information about the trial drug, such as the
dosage of oral medication, medication time, frequency, injection
drug formula, infusion rate, number of drugs, and whether ﬁts “ﬁve
taboo”. It is important to strictly implement “three- and seven-
checks”, aseptic principles, and ensure the medication standard. (3)
The observation of trial drugerelevant adverse reactions and
emergency treatment measures must be controlled. While using
the drug, the process should be thoroughly inspected. Nurses must
have good communication with participants and closely observe
each subject's vital signs. When any event occurs during the test,
nurses must closely observe the reaction after medicine adminis-
tration. Detailed information about the event must be recorded to
assist in instantly detecting future adverse events, ensure the safety
of subjects, and to avoid serious consequences. The researcher can
decide whether to open the blind to subjects depending on the
circumstances. Research nurses cannot decide to lift the blind by
themselves. After training, the quality of the blind clinical trial
signiﬁcantly improves.8
4.5.2. Duties of nurses lifting the blind
(1) Nurses are responsible for receiving and storing drugs.
Management principles include management by a speciﬁc person,
designed locks, speciﬁc counters, special refrigerators, special ac-
count records, and maintenance of a daily record of humidity and
refrigerator temperature. (2) Unblinded nurses call the interactive
voice response (IVR) system and receive grouping information for
test subjects. The nurse saves the record of participant test distri-
bution and places the record in the speciﬁc folder to avoid breaches.
(3) Drugs must be distributed according to the drug program and
drug number. The outside of the box must show the nurse's initials,
number, and medicine administration time; all information will be
carefully checked and the drug distribution completed. The drug
liquid should be prepared in a separate treatment room and others
are prohibited from entering when dispensing. To prevent
Y. Lin et al. / Chinese Nursing Research 3 (2016) 77e79 79revealing whether the subject is in the experimental or control
group based on the color of the liquid, the drug should be packaged
in a dark bag while preparing, and dark infusion should be used to
maintain blindness. (4) The name of the drug on the label that is
attached to the infusion bag should be uniform, regardless of
whether it contains the experimental or the control drug.9 (5) After
dispensing is ﬁnished, research nurses must carefully check and
carefully count the number of drugs, record the information, and
register the remaining drug and the empty box. Due to the special
nature of the test drug, the empty bottles, medicine bags, and
remaining medicines cannot be randomly discarded after use; they
must be gathered and recycled. At the end of the trial, all materials
must be recycled by a clinical pharmacologic agency; they cannot
bemixed with othermedical waste. (6) According to the dispensing
time and frequency interval, the drug must be placed in a particular
environment and will be used within the validity period. (7)
Immediately ﬁll the drug-prescribing form, accurately record the
dispensing time, and sign the form.10 If there is any concern, contact
the unblinded inspector directly. Unblinded nurses should avoid
any direct contact with participants.5. Discussion
Through the above observation during clinical trial procedures,
we found that the personal responsibility of research nurses
required some adjustment. Research nurses might violate sections
of work in the clinical trial SOP, such as revealing blinded infor-
mation to unblinded staff while charting. Individual research
nurses might think that they can assist in the completion of a
clinical trial task, and that they do not need to be familiar with or
fully understand the test program. This situation can result in
failure to handle all details according to the correct procedures
during implementation. In a double-blind trial, effort must bemade
to maintain blindness. Health-care workers who are involved in
research or subject management should not ask about or know if a
participant is in the test or control group, and must not reveal the
identity of the research nursewho knows the random results or any
other relevant information to subjects and their families. Effort
must be made to prevent events that result from blind-trial infor-
mation leaks to avoid bias caused by human factors. Only through
training and enhanced cautious behavior by research nurses,
strengthening nursing research awareness, and broadening the
nurses' understanding of clinical trials, can one avoid affecting the
objectivity of the test results.
If SOPs are not strictly followed, research nurses can face oper-
ational difﬁculties and the blind aspect of the clinical trial can be
compromised. By following consistent standard-of-care pro-
cedures, formulating a manageable workﬂow, and establishing a
clinical practice routine, the implementation capacity of research
nurses will be improved and human error in clinical trials will be
minimized.Research nurses who participate in new drug trials must
participate in drug GCP training and become familiar with all
standard test regulations to strengthen training and improve
quality. Research nurses require research thinking and conscious-
ness, and must be competent in ﬁnding problems in clinical prac-
tice, ﬁnding ways to resolve those problems, and organically
combining clinical practice and clinical trials to improve clinical
trial quality. In clinical trial, it was possible to instantly identify
problems, take effective measures, and strengthen research nurses'
professional knowledge and skills training, and to provide training
on vocational ethics and scientiﬁc attitudes.
Clinical trials in China are increasing due to the globalization of
drug development, and the number of international clinical trial
centers in China has grown in recent years. The level of our clinical
trials has gradually gained international recognition. However,
there is a shortage of research resources in our medical institutions
and there is no mature clinical trial project management system.
Because research nurses are involved in clinical trials, they must
focus on learning the basic methods of scientiﬁc research and
establishing complete nurse management methods in individual
tests to ensure that clinical trials are conducted smoothly.
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